Search

everythinglearnresearchcommunity

for

Search:↓

The registry showed that tofacitinib is promising for treating hair loss in children with alopecia areata, but more research is needed.

Alopecia areata is an autoimmune condition causing hair loss, influenced by genetics, stress, and diet, and may be prevented by a high soy oil diet.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

The analysis aims to identify the most effective and safest treatments for alopecia areata.

In Denmark from 1995 to 2016, hospital-treated alopecia areata cases increased, mostly affecting women and those over 50.

Intralesional triamcinolone acetonide can regrow hair in alopecia areata but often has temporary effects and side effects.

Use specific tools to measure quality of life in alopecia areata patients and improve future treatments.

The trial showed that a new under-the-tongue treatment for severe hair loss was somewhat effective in a small group of people.

New targeted therapies for hair loss from alopecia areata show promise, with personalized treatment expected in the future.

Half of people with Alopecia Areata may see hair regrowth within a year without treatment, but recovery is unpredictable.

No systemic treatment for alopecia areata has strong evidence of effectiveness.

Alopecia areata, a type of hair loss, is likely an autoimmune disease with a genetic link, but its exact cause is still unknown.

Non-immune factors play a significant role in alopecia areata.

Some treatments for severe hair loss work but often have side effects, with baricitinib showing the most promise.

Male gender and family history predict alopecia areata recurrence.

New research has found 14 genes linked to the risk of developing alopecia areata, improving understanding and treatment options.

Pediatricians should treat some hair loss types in children and refer others to a dermatologist.

Heat treatment increases hair loss in certain mice.

Tofacitinib is effective and safe for treating alopecia areata with a good drug survival rate.

Alopecia areata involves complex immune and genetic factors, with potential treatment targets identified, but more research is needed.

Current treatments for Alopecia Areata have mixed success, and there's a need for better, more accessible options and support for affected individuals.

Mice are useful for researching human hair loss and testing treatments, despite some differences between species.

The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.

People with alopecia areata often have lower levels of vitamin D, zinc, and folate, but more research is needed to understand if supplements can help treat it.

Tofacitinib and adalimumab are promising treatments for cicatricial alopecia with few side effects.

Most alopecia areata patients in the study were women, aged 15-49, with patchy hair loss and often had other health conditions.

People with alopecia areata have similar overall death rates as others but higher risks of death from self-harm, psychiatric issues, and lung cancer in certain cases.

COVID-19 can cause skin issues like hives, rashes, and chickenpox-like eruptions, with women aged 31-40 being the most affected.

Topical eye β-blockers may cause hair loss.

Eye drops with β-blockers may cause hair loss.